Zai Lab Ltd logo

Zai Lab Ltd (ZLAB) live share price

Zai Lab Ltd share price in USD $28.85 & INR ₹2,443.45

$28.85

▲

0.72

(2.56%)

View live Zai Lab Ltd share price in Dollar and Rupees. Guide to invest in Zai Lab Ltd from India. Also see the sentimental analysis on Indian investors investing in Zai Lab Ltd. Get details on the Indian mutual funds that are investing in Zai Lab Ltd. Get Analyst recommendations and forecasts along with all the Zai Lab Ltd's financials.

Zai Lab Ltd share price movements

  • $28.31
    $29.06

    Day's Volatility :2.6%

  • $13.48
    $36.60

    52 Weeks Volatility :63.17%

Zai Lab Ltd Returns

PeriodZai Lab LtdSector (Health Care)Index (Russel 2000)
3 Months
49.1%
-6.2%
0.0%
6 Months
60.28%
2.6%
0.0%
1 Year
6.89%
11.8%
0.0%
3 Years
-55.87%
13.3%
-19.8%

Zai Lab Ltd Key Statistics

in dollars & INR

Market Capitalization
$3.1B
Revenue TTM
$355.7M
EBITDA
$-326.9M
Earnings Per Share (EPS)
$-2.8
Profit Margin
-76.14%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-34.98%

How to invest in Zai Lab Ltd from India?

It is very easy for Indian residents to invest directly in Zai Lab Ltd from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Zai Lab Ltd stock in both rupees (INR) and dollars (USD). Search for Zai Lab Ltd or ZLAB on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Zai Lab Ltd or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Zai Lab Ltd shares which would translate to 0.029 fractional shares of Zai Lab Ltd as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Zai Lab Ltd

-46%

Period: Sep 2, 2024 to Dec 1, 2024. Change in 30 Days versus previous period

Search volume for Zai Lab Ltd on INDmoney from India has reduced in the last 30 days as on Dec 2, 2024. -46% less investors are searching Zai Lab Ltd in the last 30 days versus the previous period.

Global Institutional Holdings in Zai Lab Ltd

  • Wellington Management Company LLP

    7.24%

  • HHG PLC

    6.63%

  • Capital World Investors

    6.54%

  • Woodline Partners LP

    2.37%

  • Viking Global Investors LP

    1.98%

  • BAMCO Inc

    1.94%

Analyst Recommendation on Zai Lab Ltd

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Zai Lab Ltd(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
9
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Zai Lab Ltd

What analysts predicted

Upside of 79.59%

Current:

$28.85

Target:

$51.81

Insights on Zai Lab Ltd

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 65.83M → 102.26M (in $), with an average increase of 13.2% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -80.27M → -41.67M (in $), with an average increase of 92.6% per quarter

  • Vs ALNY

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 47.6% return, outperforming this stock by 42.7%

  • Vs VRTX

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.4% return, outperforming this stock by 98.0%

Zai Lab Ltd Financials in INR & Dollars

FY18Y/Y Change
Revenue
$129.5K
-
Net Income
$-139.1M
↑ 176.03%
Net Profit Margin
-107.4K%
-
FY19Y/Y Change
Revenue
$13.0M
↑ 9930.55%
Net Income
$-183.4M
↑ 31.85%
Net Profit Margin
-1.4K%
↑ 106021.4%
FY20Y/Y Change
Revenue
$49.0M
↑ 277.04%
Net Income
$-298.2M
↑ 62.6%
Net Profit Margin
-609.02%
↑ 803.14%
FY21Y/Y Change
Revenue
$144.3M
↑ 194.77%
Net Income
$-692.4M
↑ 132.24%
Net Profit Margin
-479.82%
↑ 129.2%
FY22Y/Y Change
Revenue
$215.0M
↑ 49.01%
Net Income
$-482.0M
↓ 30.39%
Net Profit Margin
-224.14%
↑ 255.68%
FY23Y/Y Change
Revenue
$266.7M
↑ 24.03%
Net Income
$-334.6M
↓ 30.58%
Net Profit Margin
-125.46%
↑ 98.68%
Q2 FY23Q/Q Change
Revenue
$68.9M
↑ 9.66%
Net Income
$-120.9M
↑ 320.27%
Net Profit Margin
-175.56%
↓ 129.75%
Q3 FY23Q/Q Change
Revenue
$69.2M
↑ 0.53%
Net Income
$-69.2M
↓ 42.8%
Net Profit Margin
-99.89%
↑ 75.67%
Q4 FY23Q/Q Change
Revenue
$65.8M
↓ 4.91%
Net Income
$-95.4M
↑ 38.0%
Net Profit Margin
-144.96%
↓ 45.07%
Q1 FY24Q/Q Change
Revenue
$87.1M
↑ 32.38%
Net Income
$-53.5M
↓ 43.97%
Net Profit Margin
-61.36%
↑ 83.6%
Q2 FY24Q/Q Change
Revenue
$100.5M
↑ 15.32%
Net Income
$-80.3M
↑ 50.13%
Net Profit Margin
-79.87%
↓ 18.51%
Q3 FY24Q/Q Change
Revenue
$102.3M
↑ 1.75%
Net Income
$-41.7M
↓ 48.09%
Net Profit Margin
-40.75%
↑ 39.12%
FY18Y/Y Change
Total Assets
$302.0M
↑ 20.97%
Total Liabilities
$50.9M
↑ 251.96%
FY19Y/Y Change
Total Assets
$355.2M
↑ 17.61%
Total Liabilities
$60.5M
↑ 18.83%
FY20Y/Y Change
Total Assets
$1.3B
↑ 265.37%
Total Liabilities
$128.3M
↑ 112.08%
FY21Y/Y Change
Total Assets
$1.6B
↑ 24.07%
Total Liabilities
$230.0M
↑ 79.28%
FY22Y/Y Change
Total Assets
$1.2B
↓ 24.21%
Total Liabilities
$174.5M
↓ 24.11%
FY23Y/Y Change
Total Assets
$1.0B
↓ 15.07%
Total Liabilities
$240.2M
↑ 37.6%
Q2 FY23Q/Q Change
Total Assets
$1.1B
↓ 5.44%
Total Liabilities
$174.1M
↑ 3.1%
Q3 FY23Q/Q Change
Total Assets
$1.0B
↓ 5.67%
Total Liabilities
$162.7M
↓ 6.52%
Q4 FY23Q/Q Change
Total Assets
$1.0B
↓ 0.71%
Total Liabilities
$240.2M
↑ 47.61%
Q1 FY24Q/Q Change
Total Assets
$988.4M
↓ 4.62%
Total Liabilities
$226.3M
↓ 5.79%
Q2 FY24Q/Q Change
Total Assets
$987.4M
↓ 0.11%
Total Liabilities
$283.2M
↑ 25.16%
Q3 FY24Q/Q Change
Total Assets
$985.3M
↓ 0.2%
Total Liabilities
$317.7M
↑ 12.18%
FY18Y/Y Change
Operating Cash Flow
$-97.5M
↑ 201.35%
Investing Cash Flow
$-212.6M
↑ 1937.13%
Financing Cash Flow
$144.1M
↓ 23.27%
FY19Y/Y Change
Operating Cash Flow
$-191.0M
↑ 95.83%
Investing Cash Flow
$-14.9M
↓ 92.99%
Financing Cash Flow
$219.3M
↑ 52.14%
FY20Y/Y Change
Operating Cash Flow
$-216.1M
↑ 13.11%
Investing Cash Flow
$-554.8M
↑ 3625.69%
Financing Cash Flow
$1.1B
↑ 416.38%
FY21Y/Y Change
Operating Cash Flow
$-549.2M
↑ 154.21%
Investing Cash Flow
$250.0M
↓ 145.05%
Financing Cash Flow
$820.2M
↓ 27.57%
FY22Y/Y Change
Operating Cash Flow
$-367.6M
↓ 33.06%
Investing Cash Flow
$420.0M
↑ 68.04%
Financing Cash Flow
$-1.7M
↓ 100.21%
Q2 FY23Q/Q Change
Operating Cash Flow
$-58.7M
↓ 15.28%
Investing Cash Flow
$42.7M
↑ 0.0%
Financing Cash Flow
$-1.5M
↓ 61.58%

Zai Lab Ltd Technicals Summary

Sell

Neutral

Buy

Zai Lab Ltd is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Zai Lab Ltd Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Zai Lab Ltd
Zai Lab Ltd
-6.6%
60.28%
6.89%
-55.87%
-29.38%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-9.49%
-24.18%
-8.88%
18.12%
102.78%
Biontech Se
Biontech Se
8.64%
15.09%
18.5%
-65.59%
454.0%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
-6.25%
68.21%
46.39%
47.68%
107.47%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
-0.99%
-0.44%
33.51%
129.69%
109.07%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Zai Lab Ltd
Zai Lab Ltd
NA
NA
NA
-2.56
-0.35
-0.21
NA
6.8
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
18.66
18.66
1.12
44.91
0.17
0.07
NA
272.04
Biontech Se
Biontech Se
160.8
NA
0.04
-3.06
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.84
NA
1.22
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Zai Lab Ltd
Zai Lab Ltd
Buy
$3.1B
-29.38%
NA
-76.14%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$83.0B
102.78%
18.66
33.61%
Biontech Se
Biontech Se
Buy
$28.9B
454.0%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Buy
$32.7B
107.47%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$119.6B
109.07%
32.84
-4.51%

About Zai Lab Ltd

zai lab is a biopharmaceutical company dedicated to discovering, developing and commercializing innovative medicines. our vision is to address the largest unmet medical needs and transform patients’ lives around the world. we take a unique approach to combine both in-licensed products and internal r&d; to achieve a rich pipeline. we believe our drug candidates can be truly disease modifying and bring significant benefits to patients. the company was founded in 2013 by a group of industry veterans. the founders are known as pioneers in china’s fast advancing biotech industry with a proven track record for successful chinese cfda and us fda filings and approvals. our senior management team introduced fast regulatory approval pathways in china and developed a variety of partnership models with multinational pharmaceutical companies. we endeavor to conduct world class clinical development in china and beyond. zai lab has strong backing from a leading group of healthcare investors. our inve
Organization
Zai Lab Ltd
Employees
2175
CEO
Dr. Ying Du Ph.D.
Industry
Health Technology

Important FAQs about investing in Zai Lab Ltd from India :

What is Zai Lab Ltd share price today?

Zai Lab Ltd (ZLAB) share price today is $28.85.

Can Indians buy Zai Lab Ltd shares?

Yes, Indians can invest in the Zai Lab Ltd (ZLAB) from India.

With INDmoney, you can buy Zai Lab Ltd at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Zai Lab Ltd at zero transaction cost.

How can I buy Zai Lab Ltd shares from India?

It is very easy to buy Zai Lab Ltd from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Zai Lab Ltd be purchased?

Yes, you can buy fractional shares of Zai Lab Ltd with INDmoney app.

What are the documents required to start investing in Zai Lab Ltd stocks?

To start investing in Zai Lab Ltd, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Zai Lab Ltd

Today’s highest price of Zai Lab Ltd (ZLAB) is $29.06.

Today’s lowest price of Zai Lab Ltd (ZLAB) is $28.31.

What is today's market capitalisation of Zai Lab Ltd

Today's market capitalisation of Zai Lab Ltd ZLAB is 3.1B

What is the 52 Week High and Low Range of Zai Lab Ltd

  • 52 Week High

    $36.60

  • 52 Week Low

    $13.48

How much percentage Zai Lab Ltd is down from its 52 Week High?

Zai Lab Ltd (ZLAB) share price is $28.85. It is down by 99% from its 52 Week High price of $36.60.

How much percentage Zai Lab Ltd is up from its 52 Week low?

Zai Lab Ltd (ZLAB) share price is $28.85. It is up by 1% from its 52 Week Low price of $13.48.

What are the historical returns of Zai Lab Ltd?

  • 1 Month Returns

    -6.6%

  • 3 Months Returns

    60.28%

  • 1 Year Returns

    6.89%

  • 5 Years Returns

    -29.38%

Who is the Chief Executive Officer (CEO) of Zai Lab Ltd

Dr. Ying Du Ph.D. is the current Chief Executive Officer (CEO) of Zai Lab Ltd.